Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2554-2562

  Lee, Seoung Woo ^a   Park, Geun Ho ^a   Lee, Seung Won ^a   Song, Joon Ho ^a   Hong, Kee Chun ^a   Kim, Moon Jae ^a,b  

^a Inha University School of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

Author keywords

End stage renal disease; Insulin resistance; Malnutrition; Muscle atrophy

Indexed keywords

ACTIN; INSULIN;

ADULT; AGED; ARTICLE; BODY FAT; CALCULATION; CATHETERIZATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; KIDNEY FAILURE; LEAN BODY WEIGHT; MALE; MULTIPLE REGRESSION; MUSCLE ATROPHY; MUSCLE BIOPSY; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECTUS ABDOMINIS MUSCLE;

ACTINS; BODY WEIGHT; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCULAR ATROPHY; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; REGRESSION ANALYSIS; THINNESS;

EID: 34548459465     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm204     Document Type: Article

References (50)

1. Kopple JD, Berg R, Houser H, Steinman TI, Teschan P. Nutritional status of patients with different levels of chronic renal failure. Kidney Int 1989; 36 [Suppl 27]: S184-S194
2. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 1998; 53: 773-782
3. Cianciaruso B, Brunori G, Kopple JD et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1995; 26: 475-486
4. Dwyer JT, Cunniff PJ, Maroni BJ et al. The hemodialysis(HEMO) pilot study: Nutrition program and participant characteristics at baseline. J Renal Nutr 1998; 8: 11-20
5. Meireles CL, Price SR, Pereira AML, Carvalhaes JTA, Mitch WE. Nutrition and chronic renal failure in rats: What is an optimal dietary protein? J Am Soc Nephrol 1999; 10: 2367-2372
6. Mitch WE. Malnutrition: A frequent misdiagnosis for hemodialysis patients. J Clin Invest 2002; 110: 437-439
7. Du J, Mitch WE. Identification of pathways controlling muscle protein metabolism in uremia and other catabolic conditions. Curr Opin Nephrol Hypertens 2005; 14: 378-382
8. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med 2003; 9: 344-350
9. Stitt TN, Drujan D, Clarke BA et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14: 395-403
10. Hager SR. Insulin resistance of uremia. Am J Kidney Dis 1989; 14: 272-276
11. Fliser D, Pacini G, Engelleiter R et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347
12. Mitch WE, Clark AS. Muscle protein turnover in uremia. Kidney Int 1983; 24 [Suppl 16]: S2-S8
13. Ikizler TA, Hakim RM. Nutrition in end-stage renal disease. Kidney Int 1996; 50: 343-357
14. Bergstrom J, Wang T, Lindholm B. Factors contributing to catabolism in end-stage renal disease patients. Miner Electrolyte Metab 1998; 24: 92-101
15. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470
16. Aparicio M, Cano N, Chauveau P et al. Nutritional status of haemodialysis patients: A French national cooperative study. Nephrol Dial Transplant 1999; 14: 1679-1686
17. Chauveau P, Combe C, Laville M et al. Factors influencing survival in hemodialysis patients aged older than 75 years: 2.5 year outcome study. Am J Kidney Dis 2001; 37: 997-1003
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419
19. Kelly TL, Berger N, Richardson TL. DXA body composition: Theory and practice. Appl Radiat Isot 1998; 49: 511-513
20. NKF/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000; 35 [Suppl 2]: S34-S35
21. Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol 1992; 65: 895-900
22. Detsky AS, McLauglin JR, Baker JP et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13
23. Du J, Hu Z, Mitch WE. Cellular signals activating muscle proteolysis in chronic kidney disease: A two-stage process. Int J Biochem Cell Biol 2005; 37: 2147-2155
24. Malavolti M, Mussi C, Poli M et al. Cross-calibration of eight-polar bioelectrical impedance analysis vs dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol 2003; 30: 380-391
25. Bedogni G, Malavolti M, Severi S et al. Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002; 56: 1143-1148
26. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 370-310
27. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: The role of the ubiquitin-proteasome system. N Engl J Med 1996; 335: 1897-1905
28. Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway in degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996; 271: 26690-26697
29. Du J, Wang X, Meireles CL et al. Activation of caspase 3 is an initial step triggering muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113: 115-123
30. Lee SW, Dai G, Hu Z et al. Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 2004; 15: 1537-1545
31. Rommel C, Bodine SC, Clarke BA et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI3K/Akt/mTOR and PI3K/Akt/GSK3 pathways. Nat Cell Biol 2001; 3: 1009-1013
32. Sacheck JM, Ohtsuka A. McLary SC, Goldberg AL. IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 2004; 287: E591-E601
33. Kobayashi S, Maesato K, Moriya H et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 275-280
34. Stefanovic V, Nesic V, Stojimirovic B. Treatment of insulin resistance in uremia. Int J Artif Organs 2003; 26: 100-104
35. Lim VS, Yarasheski KE, Crowley JR et al. Insulin is protein-anabolic in chronic renal failure patients. J Am Soc Nephrol 2003; 14: 2297-2304
36. Fouque D, Peng SC, Shamir E, Kopple JD. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 2000; 57: 646-654
37. Kopple JD, Brunori G, Leiserowitz M, Fouque D. Growth hormone induces anabolism in malnourished maintenance haemodialysis patients. Nephrol Dial Transplant 2005; 20: 952-958
38. Pupim LB, Heimburger O, Qureshi AR et al. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 2005; 68: 2368-2374
39. Pupim LB, Flakoll PJ, Majchrzak KM et al. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 2005; 69: 1857-1865
40. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007; 71: 146-152
41. Steinman TI. Serum albumin: Its significance in patients with ESRD. Semin Dial 2000; 13: 404-408
42. Heimburger O, Qureshi AR, Blaner WS et al. Hand-grip muscle strength, lean body mass and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000; 36: 1213-1225
43. Chevalier S, Gougeon R, Choong N, Lamarche M, Morais JA. Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging. J Gerontol A Biol Sci Med Sci 2006; 61: 156-164
44. Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptative hyperinsulinism. J Clin Invest 1962; 12: 2173-2181
45. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 1166-1173
46. Lofgren IE, Herron KL, West KL et al. Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. J Am Coll Nutr 2005; 24: 486-493
47. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63
48. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-349
49. Stenvinkel P, Wanner C, Metzger T et al. Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 2002; 62: 1791-1798
50. Multiple regression: An introduction to multiple regression performing a multiple regression on SPSS, Chapter 7. www.palgrave.com/pdfs/ 0333734718.pdf